If you suspect your menstrual changes are a medication side effect, report this through the MHRA Yellow Card scheme
A treatment for NAFLD must be able to impact liver fibrosis, aiming to reduce the rates of mortality, liver transplantation and liver-related events
Well have a detailed look at these GLP-1 patches in this blog
Methods: We systematically searched PubMed, clinicaltrials.gov, FDA and EMA product information on GLP-1 agonists and SGLT2 inhibitors in pregnancy and lactation from inception up to 19 April 2022 without language restrictions
LIPO-C is a favorite for patients looking to boost energy, burn fat, and protect lean muscle
This will increase compliance and therefore the effectiveness of the treatment for millions of patients